Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.PolyMedix, which develops acute care therapeutic drug products for infectious diseases and cardiovascular disorders, has appointed Richard Bank and Stefan Loren to its board of directors.
Subscribe to our email newsletter
Dr Bank has served as senior portfolio manager, managing director and senior vice president of the Liberty View Health Sciences Fund, a division of Liberty View Capital Management, a Lehman Brothers company.
Dr Loren is an industry consultant with Westwicke Partners in Baltimore. Dr Loren has received a PhD in organic/pharmaceutical chemistry from the University of California at Berkeley and a BA from the University of California at San Diego.
Nicholas Landekic, president and CEO of PolyMedix, said: “I greatly appreciate Dr Bank and Dr Loren being willing to share their time and expertise with PolyMedix. It is a great privilege for any company to have such renowned and highly qualified pharmaceutical industry experts on its board.”